Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies

Multicenter diagnostic study for IgG4+MOLPS, Castleman's disease, and other polyclonal hypergammopathies - IgG4 prospective diagnostic study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002312

Enrollment

100

Registered

2009-08-10

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4+MOLPS, Castleman&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, IgG4+MOLPS 2, Other polyclonal hypergammopathy; Castleman's disease, Crow-Fukase syndrome, male Sjogren's syndrome, etc. 3, age morethan 19 yrs 4, written informed consent

Exclusion criteria

Exclusion criteria: Distinct monoclonal gammopathy such as Myeloma, Macroglobulinemia.

Design outcomes

Primary

Measure	Time frame
Definition of diagnostic criteria of IgG4+MOLPS; assessment of glucocorticoid response.	—

Secondary

Measure	Time frame
Collection of clinical data, tissue, serum and lymphocytes. Proteomics and genomics analysis.	—

Countries

Japan

Contacts

Public ContactYasufumi Masaki

Kanazawa Medical University Hematology & Immunology

yasum@kanazawa-med.ac.jp076-286-3511

Outcome results